The effects of COVID-19 were felt throughout the WW Spine Market with dramatic Q220 declines in both the US and international markets.
COVID-19 stifled the Spine Hardware Market in Q220, driving WW revenues down -26.4% in the quarter, with the US at -30.5%. The US Spinal Fusion Market took the hardest hit, with that market seeing a -31.4% decline in Q220 vs US Disc Replacement and VCF Markets at -26.6% and -24.6%, respectively, according to SmartTRAK Financial Dashboard. Needham estimates that Medtronic* gained the most spine share in Q220, with DePuy Synthes* losing the most.
Among the many topics covered in the comprehensive Q220 Spine Market Recap* are:
- Complete Spine Market Overview
- Spine Companies' Revenues and Shares
- Top Players See Rebounds at Quarter’s End
- BTIG and Globus Surveys Suggesting Q3 Procedure Volumes
- Q220 Regulatory News and Highlights
It is important to note that this past quarter included an extra month of recovery after COVID shutdown due to Medtronic's fiscal calendar. Looking forward, a BTIG survey of US spine surgeons indicates that Globus* and NuVasive* are among companies expected to take share over the next year, while Medtronic, DePuy Synthes and Stryker* are expected to ...
Read the entire Q220 Spine Market Recap including news, data, charts, company revenues and analysis*
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
